subject area of
- A brief review of the past and future of platelet P2Y12 antagonist Academic Article
- A global view of atherothrombosis: baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial Academic Article
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (caprie) Academic Article
- Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus Academic Article
- An analysis of mortality rates with dual-antiplatelet therapy in the primary prevention population of the charisma trial Academic Article
- Anti-platelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma Academic Article
- Antiplatelet agents in cardiology: the choice of therapy Academic Article
- Antiplatelet and anticoagulant therapy in the secondary prevention of ischemic heart disease Academic Article
- Antiplatelet drug therapy moderates immune-mediated liver disease and inhibits viral clearance in mice infected with a replication-deficient adenovirus Academic Article
- Antiplatelet medications and their indications in preventing and treating coronary thrombosis Academic Article
- Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B Academic Article
- Antithrombotic therapy with intracoronary stenting Academic Article
- Aspirin and clopidogrel resistance: An emerging clinical entity Academic Article
- Aspirin to prevent cardiovascular disease: The association of aspirin dose and clopidogrel with thrombosis and bleeding Academic Article
- Association between inflammatory biomarkers and platelet aggregation in patients under chronic clopidogrel treatment Academic Article
- Benefit of clopidogrel over aspirin is amplified in patients with a history of ischemic events Academic Article
- Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease Academic Article
- Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial Academic Article
- Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the clopidogrel for the reduction of events during observation (credo) trial Academic Article
- Bleeding, mortality, and antiplatelet therapy: Results from the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance (charisma) trial Academic Article
- Bleeding-associated outcomes with preoperative clopidogrel use in on- and off-pump coronary artery bypass Academic Article
- Can N-acetylcysteine reverse the antiplatelet effects of clopidogrel? An in vivo and vitro study Academic Article
- Clinical implications of percutaneous coronary intervention-clopidogrel in unstable angina to prevent recurrent events (PCI-CURE) study: a US perspective Academic Article
- Clinical outcomes according to permanent discontinuation of clopidogrel or placebo in the charisma trial Academic Article
- Clinical outcomes of patients with diabetic nephropathy randomized to clopidogrel plus aspirin versus aspirin alone (a post hoc analysis of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance [CHARISMA] trial) Academic Article
- Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: Rationale and design of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance (charisma) trial Academic Article
- Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events Academic Article
- Clopidogrel and aspirin versus aspirin alone for the prevention of stroke in patients with a history of atrial fibrillation: Subgroup analysis of the charisma randomized trial Academic Article
- Clopidogrel and coronary stenting: what is the next question? Academic Article
- Clopidogrel is associated with better in-hospital and 30-day outcomes than ticlopidine after coronary stenting Academic Article
- Clopidogrel pretreatment in ST-elevation myocardial infarction patients transferred for percutaneous coronary Intervention Academic Article
- Clopidogrel with aspirin is the optimal antiplatelet regimen for intracoronary stenting Academic Article
- Comparison of long-term usefulness-of clopidogrel therapy after the first percutaneous coronary intervention or coronary artery bypass grafting versus that after the second or repeat intervention Academic Article
- Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators Academic Article
- Cost-effectiveness of clopidogrel plus aspirin versus aspirin alone for secondary prevention of cardiovascular events: Results from the charisma trial Academic Article
- Dual or mono antiplatelet therapy for patients with acute ischemic stroke or transient ischemic attack: Systematic review and meta-analysis of randomized controlled trials Academic Article
- Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention - a randomized controlled trial Academic Article
- Economic evaluation of clopidogrel plus aspirin for secondary prevention of cardiovascular events in canada for patients with established cardiovascular disease: Results from the charisma trial Academic Article
- Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with c-reactive protein Academic Article
- Effect of clopidogrel on the rate and functional severity of stroke among high vascular risk patients a prespecified substudy of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management and avoidance (charisma) trial Academic Article
- Effect of clopidogrel plus asa vs. Asa early after tia and ischaemic stroke: A substudy of the charisma trial Academic Article
- Effect of clopidogrel pretreatment on inflammatory marker expression in patients undergoing percutaneous coronary intervention Academic Article
- Effect of clopidogrel pretreatment on periprocedural rise in c-reactive protein after percutaneous coronary intervention Academic Article
- Effects of clopidogrel on the pharmacokinetics of sibutramine and its active metabolites Academic Article
- Efficacy and safety of clopidogrel pretreatment before percutaneous coronary intervention with and without glycoprotein iib/iiia inhibitor use Academic Article
- Ethnic variation in adverse cardiovascular outcomes and bleeding complications in the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance (charisma) study Academic Article
- Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: Design and rationale of the gravitas trial Academic Article
- Evolution of improved antithrombotic and antiplatelet agents: Genesis of the comparison of abciximab complications with hirulog and back-up abciximab events trial (cachet) Academic Article
- Extracardiac vascular disease and effectiveness of sustained clopidogrel treatment Academic Article
- High-sensitivity c-reactive protein and clopidogrel treatment in patients at high risk of cardiovascular events: A substudy from the charisma trial Academic Article
- Impact of chronic antiplatelet therapy before hospitalization on ischemic and bleeding events in invasively managed patients with acute coronary syndromes: the ACUITY trial Academic Article
- Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery: a multicenter analysis Academic Article
- Impact of proton pump inhibitor therapy on the efficacy of clopidogrel in the CAPRIE and CREDO trials Academic Article
- Incidence and clinical course of thrombotic thrombocytopenic purpura due to ticlopidine following coronary stenting Academic Article
- Influence of genetic polymorphisms on the effect of high-and standard-dose clopidogrel after percutaneous coronary intervention the gift (genotype information and functional testing) study Academic Article
- Influence of smoking on the antiplatelet effect of clopidogrel differs according to clopidogrel dose: Insights from the GRAVITAS trial Academic Article
- Influence of timing of clopidogrel treatment on the efficacy and safety of bivalirudin in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention: an analysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial Academic Article
- Is there a clinically significant interaction between calcium channel antagonists and clopidogrel? Results from the clopidogrel for the reduction of events during observation (credo) trial Academic Article
- Is there a clinically significant interaction between calcium channel antagonists and clopidogrel?: results from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial Academic Article
- Lack of adverse clopidogrel-atorvastatin clinical interaction from secondary analysis of a randomized, placebo-controlled clopidogrel trial Academic Article
- Lack of clopidogrel pretreatment effect on the relative efficacy of bivalirudin with provisional glycoprotein iib/iiia blockade compared to heparin with routine glycoprotein iib/iiia blockade - a replace-2 substudy Academic Article
- Lack of evidence of a clopidogrel-statin interaction in the charisma trial Academic Article
- Long-term cost effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel given for up to one year after percutaneous coronary intervention - results from the clopidogrel for the reduction of events during observation (credo) trial Academic Article
- Meta-analysis of randomized and registry comparisons of ticlopidine with clopidogrel after stenting Academic Article
- Optimal timing for pre-treatment with before percutaneous the initiation of 300 mg clopidogrel coronary intervention Academic Article
- Optimal treatment and current situation in reperfusion after thrombolysis for acute myocardial infarction Academic Article
- Oral antiplatelet therapy for percutaneous coronary revascularization Academic Article
- Patients with peripheral arterial disease in the charisma trial Academic Article
- Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the charisma trial Academic Article
- Percutaneous coronary intervention in diabetic patients with non-st-segment elevation acute coronary syndromes Academic Article
- Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable coronary artery disease Academic Article
- Pilot study of the antiplatelet effect of increased clopidogrel maintenance dosing and its relationship to cyp2c19 genotype in patients with high on-treatment reactivity Academic Article
- Platelet function monitoring in patients with coronary artery disease Academic Article
- Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention a time-dependent analysis of the gauging responsiveness with a verifynow p2y12 assay: Impact on thrombosis and safety (gravitas) trial Academic Article
- Platelet-mediated thrombosis and drug-eluting stents Academic Article
- Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade Academic Article
- Reduction in the need for hospitalization for recurrent ischemic events and bleeding with clopidogrel instead of aspirin Academic Article
- Relationship between activated clotting time and ischemic or hemorrhagic complications - analysis of 4 recent randomized clinical trials of percutaneous coronary intervention Academic Article
- Relationship between baseline inflammatory markers, antiplatelet therapy, and adverse cardiac events after percutaneous coronary intervention an analysis from the clopidogrel for the reduction of events during observation trial Academic Article
- Risk stratification for patients undergoing nonurgent percutaneous coronary intervention using n-terminal pro-b-type natriuretic peptide: A clopidogrel for the reduction of events during observation (credo) substudy Academic Article
- Smoking, clopidogrel, and mortality in patients with established cardiovascular disease Academic Article
- Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial Academic Article
- Statins do not affect platelet inhibition with clopidogrel during coronary stenting Academic Article
- Structures of cytochrome P450 2B4 complexed with the antiplatelet drugs ticlopidine and clopidogrel Academic Article
- Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery Academic Article
- Synthesis of biologically active piperidine metabolites of clopidogrel: determination of structure and analyte development Academic Article
- Tailored antiplatelet therapy in a patient with ITP and clopidogrel resistance Academic Article
- The duration of pretreatment with ticlopidine prior to stenting is associated with the risk of procedure-related non-q-wave myocardial infarctions Academic Article
- The efficacy and safety of short- and long-term dual antiplatelet therapy in patients with mild or moderate chronic kidney disease: Results from the clopidogrel for the reduction of events during observation (credo) trial Academic Article
- The future of antiplatelet therapy: optimizing management in patients with acute coronary syndrome Academic Article
- The influence of body mass index on mortality and bleeding among patients with or at high-risk of atherothrombotic disease Academic Article
- The relationship between cyp2c19 polymorphisms and ischaemic and bleeding outcomes in stable outpatients: The charisma genetics study Academic Article
- The relative efficacy and safety of clopidogrel in women and men a sex-specific collaborative meta-analysis Academic Article
- Ticlopidine pretreatment before coronary stenting is associated with sustained decrease in adverse cardiac events - data from the evaluation of platelet iib/iiia inhibitor for stenting (epistent) trial Academic Article
- Triple antiplatelet therapy does not increase femoral access bleeding with vascular closure devices Academic Article
- Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival - results from the do tirofiban and reopro give similar efficacy outcome trial (target) Academic Article
- Update on clinical trials of antiplatelet therapy for cerebrovascular diseases Academic Article
- Variability in platelet responsiveness to clopidogrel among 544 individuals Academic Article
- Variable response to antiplatelet therapy: what does it mean to clinicians? Academic Article
- X-ray crystal structure of the cytochrome p450 2b4 active site mutant f297a in complex with clopidogrel: Insights into compensatory rearrangements of the binding pocket Academic Article